(Q57740688)

English

Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure

article

In more languages

Statements

scholarly article

0 references

Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure (English)

0 references

1 reference

based on heuristic

inferred from title

Torsten Haferlach

9

object named as

T Haferlach

0 references

Claudia Haferlach

10

object named as

C Haferlach

0 references

Susanne Schnittger

5

object named as

S Schnittger

0 references

author name string

V Grossmann

1

0 references

A Kohlmann

2

0 references

H-U Klein

3

0 references

S Schindela

4

0 references

F Dicker

6

0 references

M Dugas

7

0 references

W Kern

8

0 references

publication date

21 January 2011

0 references

0 references

25

0 references

671-680

0 references

4

0 references

https://scigraph.springernature.com/pub.10.1038/leu.2010.309

0 references

Direct selection of human genomic loci by microarray hybridization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Microdroplet-based PCR enrichment for large-scale targeted sequencing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Molecular diagnostics in acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

New insights to the MLL recombinome of acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Genome sequencing in microfabricated high-density picolitre reactors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Fast and accurate long-read alignment with Burrows-Wheeler transform

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

A SNP discovery method to assess variant allele probability from next-generation resequencing data

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

High-resolution copy-number variation map reflects human olfactory receptor diversity and evolution

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

A role for BK channels in heart rate regulation in rodents

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Role of KCNMA1 gene in breast cancer invasion and metastasis to brain

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Massively parallel sequencing of ataxia genes after array-based enrichment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Molecular genetics of human leukemias: new insights into therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

21 January 2018

Perspectives on RUNX genes: an update

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.309

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57740688&oldid=1738922028"